BIXT
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Jul 30 closing price
Capitalization
8.04M
CCCC
Price
$2.04
Change
-$0.11 (-5.09%)
Updated
Jul 31, 04:59 PM (EDT)
Capitalization
153.38M
6 days until earnings call
Interact to see
Advertisement

BIXT vs CCCC

Header iconBIXT vs CCCC Comparison
Open Charts BIXT vs CCCCBanner chart's image
Bioxytran
Price$0.09
Change-$0.00 (-0.00%)
Volume$24.8K
Capitalization8.04M
C4 Therapeutics
Price$2.04
Change-$0.11 (-5.09%)
Volume$6.48K
Capitalization153.38M
BIXT vs CCCC Comparison Chart in %
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. CCCC commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a StrongBuy and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (BIXT: $0.09 vs. CCCC: $2.16)
Brand notoriety: BIXT and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 31% vs. CCCC: 66%
Market capitalization -- BIXT: $8.04M vs. CCCC: $153.38M
BIXT [@Biotechnology] is valued at $8.04M. CCCC’s [@Biotechnology] market capitalization is $153.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $239.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 0 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • BIXT’s FA Score: 0 green, 5 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 5 TA indicator(s) are bullish while CCCC’s TA Score has 5 bullish TA indicator(s).

  • BIXT’s TA Score: 5 bullish, 3 bearish.
  • CCCC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than CCCC.

Price Growth

BIXT (@Biotechnology) experienced а +0.44% price change this week, while CCCC (@Biotechnology) price change was -10.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.01%. For the same industry, the average monthly price growth was +17.74%, and the average quarterly price growth was +41.54%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($153M) has a higher market cap than BIXT($8.05M). BIXT YTD gains are higher at: 0.556 vs. CCCC (-40.000). BIXT has higher annual earnings (EBITDA): -2.38M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. BIXT (4.35K). BIXT has less debt than CCCC: BIXT (1.26M) vs CCCC (64.4M). CCCC has higher revenues than BIXT: CCCC (39.8M) vs BIXT (0).
BIXTCCCCBIXT / CCCC
Capitalization8.05M153M5%
EBITDA-2.38M-102.74M2%
Gain YTD0.556-40.000-1%
P/E RatioN/AN/A-
Revenue039.8M-
Total Cash4.35K215M0%
Total Debt1.26M64.4M2%
FUNDAMENTALS RATINGS
BIXT: Fundamental Ratings
BIXT
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIXTCCCC
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VBNK11.800.10
+0.85%
VersaBank
SHW331.98-4.99
-1.48%
Sherwin-Williams Company (The)
SFL9.34-0.14
-1.48%
SFL Corp Ltd
VAL48.69-2.25
-4.42%
Valaris Limited
USAU10.37-0.80
-7.16%
US Gold Corp

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CCCC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+3.91%
CCCC - BIXT
22%
Poorly correlated
-4.00%
IMUX - BIXT
22%
Poorly correlated
-1.82%
WVE - BIXT
20%
Poorly correlated
-1.92%
DOMH - BIXT
20%
Poorly correlated
-9.18%
BSEM - BIXT
11%
Poorly correlated
+1.41%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-4.00%
BEAM - CCCC
53%
Loosely correlated
+1.10%
CRBU - CCCC
51%
Loosely correlated
+4.59%
PRME - CCCC
50%
Loosely correlated
+2.35%
KYMR - CCCC
50%
Loosely correlated
+0.85%
IDYA - CCCC
50%
Loosely correlated
+2.05%
More